Trials / Completed
CompletedNCT02596100
A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Portola Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This is a single center open label randomized 4-period 2-sequence replicated crossover design study. A total of 52 healthy subjects will be randomized.
Detailed description
Serial blood samples will be obtained for PK evaluation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Betrixaban |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2015-11-04
- Last updated
- 2023-08-08
Source: ClinicalTrials.gov record NCT02596100. Inclusion in this directory is not an endorsement.